The intended research project focuses on the supply chain disruptions that medical/pharmaceutical industries are currently facing in the Novel Coronavirus Outbreak, due to the suppliers’ strategic hoarding and consumers’ panic buying behavior under psychological and behavioral uncertainties. Specifically, this proposed research project explores: factors that delay the resilience of medical/pharmaceutical industries’ supply chain disruptions caused by the Novel Coronavirus Outbreak; and the feasibility of two countermeasures that we propose: (1) establishing a collaborative stock sharing/transshipment system; and (2) making an incentive contract with a potential second source that can produce highly customized medical/pharmaceutical items (e.g., ventilators, protective clothing for or a new drug for novel viruses).
The research is funded by 2019 Novel Coronavirus (COVID-19) Rapid Research Funding of the Canadian Institute of Health Research (CIHR).
Principal Investigator (PI)
The Candian Institute of Health Research (CIHR)
Year Project Started:
Solis Adriano, Asgary Ali and Wakolbiger Tina
York University and Vienna University of Economics and Business
(e.g type 1000 for 1,000)